CDMO Technology Domain

Analytical Methods & PAT — Page 2

Process Analytical Technology (PAT) and advanced characterisation: Raman spectroscopy, NIR, HPLC, ICP-MS for heavy metals, and botanical adulterant profiling.

28

dossiers

Intracellular Defense & IV-Alternatives

De Novo Generative AI Drug Design: Clinical Progress and Methodological Landscape

Developing novel therapeutic molecules with high specificity and optimized pharmacological profiles rapidly, particularly for challenging targets, requires innovative and efficient design methodologies beyond traditional discovery pipelines.

Intracellular Defense & IV-Alternatives

Oxidative Stress Mitigation in Nutraceutical Stability: Packaging and Formulation Strategies

Nutraceutical dosage forms face significant degradation due to oxidative stress, driven by moisture, oxygen, and light. This presents a challenge for maintaining stability across supply-chain conditions and long shelf lives.

AgingProbioticsDrug Stability

Intracellular Defense & IV-Alternatives

Non-Destructive Raman Spectroscopy for PAT-Based Botanical Contaminant Detection

Ensuring real-time quality control of botanical APIs is hindered by the need to detect trace contaminants, such as pesticide residues or adulterants, in heterogeneous botanical matrices while meeting regulatory sensitivity requirements.

AgingSpectrum Analysis, RamanSpectrum AnalysisQuality Control

Cellular Longevity & Senolytics

Synergistic Modulation of Cellular Senescence Biomarkers by Target-Specific Nutraceutical Matrices

Developing a nutraceutical matrix that precisely modulates senescence-related biomarkers requires integrating senolytic activity, SASP suppression, and mitochondrial restoration within a single formulation while ensuring in vitro reproducibility and scalability.

SenotherapeuticsCellular SenescenceNADInflammation

Custom Formulation Available

Need a Dossier Built Around Your Molecule?

Our R&D team will conduct a Paid Discovery Audit and build a proprietary clinical dossier for your specific active ingredient or therapeutic target. Full IP transfer included.